Sildenafil Citrate Tablet, Film Coated
Product Images NDC 67296-2241

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 67296-2241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (Logo1)

Image Description (Logo1)
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of sildenafil, the active ingredient in Sildenafil Citrate 50 mg film-coated tablets by Redpharm Drug. The diagram depicts the molecular formula with labeled atoms and bonds.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph depicting the effect on systolic blood pressure (mmHg) over time (hours) post-dose for Sildenafil 100 mg and placebo. The x-axis represents time from pre-dose to 24 hours, and the y-axis shows systolic blood pressure changes. Two lines with markers compare the blood pressure changes for Sildenafil and placebo groups across the time points.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph showing the change in systolic blood pressure (SBP) in mmHg over time postdose (hours) for two treatments: Doxazosin plus Placebo and Doxazosin plus Sildenafil 25 mg. The graph spans from 0 to 8 hours postdose, with SBP changes ranging from -40 to 20 mmHg. The Doxazosin plus Sildenafil 25 mg line shows a greater decrease in SBP compared to Doxazosin plus Placebo over the time course.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
Line graph depicting change in systolic blood pressure (SBP) in mmHg over time postdose (hours) comparing two treatments: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg. The graph shows measurements from 0 to 8 hours after dose administration.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
Line graph depicting the effect of Doxazosin combined with Sildenafil 100 mg versus Doxazosin combined with placebo on blood pressure over time. The y-axis measures blood pressure in mmHg, ranging from -50 to 40, and the x-axis shows time after dosing in hours from 0 to 8. The graph compares two groups, illustrating blood pressure changes after dosing.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A pharmacokinetic curve graph showing plasma concentrations (ng/ml) of Sildenafil over time post dose (hours) up to 24 hours. The plotted line with circular markers represents the data for the commercial tablet formulation. Concentrations peak early and decline over time.*
FDA Label Image

Figure-6-1 (Figure 6 1)

Figure-6-1 (Figure 6 1)
A bar chart showing the percentage of patients at endpoint categorized by baseline score, with multiple stacked bars indicating different groups labeled 0 to 5. The x-axis represents baseline scores from 0 to 5, and the y-axis shows the percentage of patients at endpoint ranging from 0% to 80%. Each baseline score group has multiple bars with varying heights, reflecting distribution across categories labeled in the legend.*
FDA Label Image

Figure-6-2 (Figure 6 2)

Figure-6-2 (Figure 6 2)
A bar graph showing the percentage of patients at endpoint categorized by baseline score for sildenafil citrate. The x-axis represents baseline scores from 0 to 5, and the y-axis indicates the percentage of patients up to 80%. Different bars within each baseline score correspond to categories labeled 0 through 5, distinguished by varying shades and patterns in the legend.*
FDA Label Image

Figure-7 (Figure 7)

Figure-7 (Figure 7)
A vertical bar chart showing the percentage of patients reporting improvement with different treatments: placebo (24%), sildenafil citrate 25 mg (63%), sildenafil citrate 50 mg (74%), and sildenafil citrate 100 mg (82%). The x-axis lists the treatment groups with sample sizes, and the y-axis shows percentage improvement from 0 to 100%.*
FDA Label Image

Label-100mg-30s-indrad (Sildenafiltablet 100mg 30tablets Indrad)

Label-100mg-30s-indrad (Sildenafiltablet 100mg 30tablets Indrad)
Label for Sildenafil Tablets, USP 100 mg film-coated tablets in a 30-tablet package. The label includes storage instructions, dosage information, manufacturer details (Torrent Pharmaceuticals LTD, India), and a barcode. It indicates the product is prescription-only and manufactured for Torrent Pharma Inc., Basking Ridge, NJ.*
FDA Label Image

Label-100mg-30s-dahej (Sildenafiltablets 100mg 30tablets Dahej)

Label-100mg-30s-dahej (Sildenafiltablets 100mg 30tablets Dahej)
Label for Sildenafil Tablets, USP 100 mg, film-coated oral tablets. The label indicates a count of 30 tablets, manufactured by Torrent Pharmaceuticals Ltd., India, and for Torrent Pharma Inc., NJ. It includes storage instructions, dosage note, and a barcode. The label states "Rx only."*
FDA Label Image

Label-25mg-30s-dahej (Sildenafiltablets 25mg 30tablets Dahej)

Label-25mg-30s-dahej (Sildenafiltablets 25mg 30tablets Dahej)
Label for Sildenafil Tablets USP, 25 mg, film-coated oral tablets. The package contains 30 tablets and is labeled for prescription use only (Rx only). It is manufactured by Torrent Pharmaceuticals LTD and distributed by Torrent Pharma INC. The label includes storage instructions and a barcode.*
FDA Label Image

Label-25mg-30s-indrad (Sildenafiltablets 25mg 30tablets Indrad)

Label-25mg-30s-indrad (Sildenafiltablets 25mg 30tablets Indrad)
Label for Sildenafil Tablets, USP 25 mg by Torrent Pharma. The film-coated tablet label includes medication details, storage instructions, manufacturer (Torrent Pharmaceuticals LTD., India), and prescribing information link. The package size is 30 tablets, marked with NDC 13668-186-30 and Rx only.*
FDA Label Image

Label-50mg-30s-dahej (Sildenafiltablets 50mg 30tablets Dahej)

Label-50mg-30s-dahej (Sildenafiltablets 50mg 30tablets Dahej)
Label for Sildenafil Tablets, USP 50 mg film-coated tablets in a package of 30 tablets. The label includes storage instructions and a dosing note directing to accompanying prescribing information. It lists Torrent Pharmaceuticals LTD as the manufacturer in India and Torrent Pharma INC as the distributor in New Jersey. The label features a barcode and states the product is Rx only.*
FDA Label Image

Label-50mg-30s-indrad (Sildenafiltablets 50mg 30tablets Indrad)

Label-50mg-30s-indrad (Sildenafiltablets 50mg 30tablets Indrad)
Label for Sildenafil Tablets, USP 50 mg film-coated tablets. The label indicates a package of 30 tablets, manufactured by Torrent Pharmaceuticals Ltd and labeled for Torrent Pharma Inc. Includes storage instructions and prescription-only designation. NDC 13668-187-30 is visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.